Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
200.86B
Market cap200.86B
Price-Earnings ratio
11.69
Price-Earnings ratio11.69
Dividend yield
4.01%
Dividend yield4.01%
Average volume
16.58M
Average volume16.58M
High today
$80.01
High today$80.01
Low today
$76.03
Low today$76.03
Open price
$78.28
Open price$78.28
Volume
18.47M
Volume18.47M
52 Week high
$134.63
52 Week high$134.63
52 Week low
$75.93
52 Week low$75.93

MRK News

Simply Wall St 11h
Merck Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1

experienced a 2.98% share price increase over the past week, during which several key developments occurred. The company reaffirmed its 2025 financial guidance,...

Merck Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1
Benzinga 14h
Merck's Q1 Earnings Beat Wall Street, Adjusts 2025 Profit Outlook As Tariffs May Result In Incremental Cost Of $200 Million

Merck & Co. Inc MRK reported the first-quarter 2025 adjusted earnings of $2.22 per share, up 7% year over year (+12% on constant currency), beating the consensu...

Merck's Q1 Earnings Beat Wall Street, Adjusts 2025 Profit Outlook As Tariffs May Result In Incremental Cost Of $200 Million
Quartz 16h
Google, Merck, PepsiCo, Procter & Gamble: Stocks to watch today

After a rally Wednesday, stock futures were pointing lower Thursday morning, as bearish signals on U.S.-China trade, fresh Fed data, and a packed slate of earni...

Analyst ratings

63%

of 27 ratings
Buy
63%
Hold
37%
Sell
0%

More MRK News

Seeking Alpha 16h
Halozyme files patent lawsuit against Merck over injectable Keytruda

Halozyme Therapeutics (NASDAQ:HALO) on Thursday announced a lawsuit against Merck (NYSE:MRK) over allegations that an injectable version of the New Jersey-based...

Halozyme files patent lawsuit against Merck over injectable Keytruda
Sherwood News 17h
Merck says it will eat $200 million in tariff costs

Merck says it will eat $200 million in tariff costs German pharmaceutical giant Merck said in a Thursday earnings report that it will take a $200 million hit i...

Merck says it will eat $200 million in tariff costs
TipRanks 18h
Merck sees $200M hit from tariffs in 2025

Merck (MRK) says its 2005 outlook includes the impact of tariffs implemented to date by the U.S. government on imports from other countries, plus the tariffs im...

Benzinga 1d
Merck Stock Slumps Ahead Of Q1 Earnings: Can Bulls Find Relief In Buying Pressure?

Merck & Co Inc MRK will be reporting its first-quarter earnings on Thursday before the market opens. Wall Street expects earnings per share of $2.14 and revenue...

Merck Stock Slumps Ahead Of Q1 Earnings: Can Bulls Find Relief In Buying Pressure?
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.